These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7031934

  • 1. Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.
    Fisher RI, Terry WD, Hodes RJ, Rosenberg SA, Makuch R, Gordon HG, Fisher SG.
    Surg Clin North Am; 1981 Dec; 61(6):1267-77. PubMed ID: 7031934
    [No Abstract] [Full Text] [Related]

  • 2. Surgical adjuvant therapy for malignant melanoma.
    Pinsky CM, Oettgen HF.
    Surg Clin North Am; 1981 Dec; 61(6):1259-66. PubMed ID: 7031933
    [No Abstract] [Full Text] [Related]

  • 3. Adjuvant chemoimmunotherapy stage I/II malignant melanoma.
    Knost JA, Reynolds V, Greco FA, Oldham RK.
    J Surg Oncol; 1982 Mar; 19(3):165-70. PubMed ID: 7040820
    [No Abstract] [Full Text] [Related]

  • 4. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma.
    O'Connor TP, Labandter HP, Hiles RW, Bodenham DC.
    Br J Plast Surg; 1978 Oct; 31(4):317-22. PubMed ID: 361132
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Results of adjuvant BCG immunotherapy in malignant melanoma.
    Wätzig V, Knopf B.
    Arch Geschwulstforsch; 1981 Oct; 51(6):493-6. PubMed ID: 7332442
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.
    Veronesi U, Adamus J, Aubert C, Bajetta E, Beretta G, Bonadonna G, Bufalino R, Cascinelli N, Cocconi G, Durand J, De Marsillac J, Ikonopisov RL, Kiss B, Lejeune F, MacKie R, Madej G, Mulder H, Mechl Z, Milton GW, Morabito A, Peter H, Priario J, Paul E, Rumke P, Sertoli R, Tomin R.
    N Engl J Med; 1982 Oct 07; 307(15):913-6. PubMed ID: 7050717
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK, Ibrahim EM, Evers JA, Thomas JW, Murray RN, Spinelli JJ.
    Can Med Assoc J; 1983 Jun 01; 128(11):1291-5. PubMed ID: 6342739
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
    Byrne MJ, Van Hazel G, Reynolds PM, Lemish WM, Holman CD.
    J Surg Oncol; 1983 Jun 01; 23(2):114-6. PubMed ID: 6343725
    [Abstract] [Full Text] [Related]

  • 11. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
    Morton DL, Eilber FR, Holmes EC, Sparks FC, Ramming K.
    Med Clin North Am; 1976 May 01; 60(3):431-9. PubMed ID: 1271888
    [Abstract] [Full Text] [Related]

  • 12. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP.
    Arch Surg; 1973 Apr 01; 106(4):503-6. PubMed ID: 4572347
    [No Abstract] [Full Text] [Related]

  • 13. Adjuvant therapy of malignant melanoma.
    Vosika GJ.
    Minn Med; 1979 Jul 01; 62(7):515-7. PubMed ID: 386072
    [No Abstract] [Full Text] [Related]

  • 14. Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma.
    Lipton A, Harvey HA, Lawrence B, Gottlieb R, Kukrika M, Dixon R, Graham W, Miller S, Heckard R, Schelzel D, White DS.
    Cancer; 1983 Jan 01; 51(1):57-60. PubMed ID: 6821809
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant therapy for melanoma.
    Sondak VK, Wolfe JA.
    Curr Opin Oncol; 1997 Mar 01; 9(2):189-204. PubMed ID: 9161800
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant therapy for malignant melanoma.
    Kaiser LR, Burk MW, Morton DL.
    Surg Clin North Am; 1981 Dec 01; 61(6):1249-57. PubMed ID: 7313933
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC, Cosimi AB, Carey RW, Kaufman SD.
    Surgery; 1978 Jun 01; 83(6):677-81. PubMed ID: 644461
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.
    Can Med Assoc J; 1983 Apr 15; 128(8):929-33. PubMed ID: 6339024
    [Abstract] [Full Text] [Related]

  • 19. Surgical treatment of malignant melanoma.
    Rosenberg SA.
    Cancer Treat Rep; 1976 Feb 15; 60(2):159-63. PubMed ID: 769968
    [Abstract] [Full Text] [Related]

  • 20. Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases.
    Morton DL, Eilber FR, Holmes EC, Ramming KP.
    Aust N Z J Surg; 1978 Feb 15; 48(1):49-52. PubMed ID: 276348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.